Hosted on MSN11mon
Alcon's (ALC) Vivity EDOF IOL Achieves One Million MilestoneThe company’s revolutionary presbyopia-correcting intraocular lens (PCIOL) option has expanded the patient candidacy pool by addressing the diverse vision needs of patients who desire less ...
Presbyopia remains one of the most challenging optical problems in cataract and refractive surgery. Different approaches to treat presbyopia have been studied in recent years. These include ...
Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...
In this Healio Video Perspective from Hawaiian Eye 2025, Jeffrey Whitman, MD, of Key-Whitman Eye Center, discusses the positive impact of the Tecnis Odyssey IOL on his practice.
Hosted on MSN11mon
Alcon's (ALC) New Launch Strengthens IOL Innovation LeadershipBoth of Alcon’s presbyopia-correcting IOLs (PCIOL ... treated by removing the eye's cloudy natural lens and surgically replacing it with an IOL. The company-provided data shows that more ...
Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...
2020 Weighing Multifocal IOL Options for Presbyopia Correction Is a trifocal or an extended-depth-of-focus intraocular lens the best way to go? Dr Sumit (Sam) Garg considers the latest data.
Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US, and seems to be becoming more of a ...
008). Topline data were announced from a phase 3 trial evaluating Brimochol TM preservative-free (PF), an investigational pupil-modulating therapeutic, in adults with presbyopia. Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results